Documento fuente o registro público

FDA 510(k) K230349 — Lyra RSV+hMPV Assay

FDA 510(k) index record K230349. Device: Lyra RSV+hMPV Assay. Applicant as listed: Quidel Corporation. Decision date: 2023-03-10.

OtherU.S. Food and Drug Administration (FDA)2023-03-10

Fuente

"device_name": "Lyra RSV+hMPV Assay"

Esta entrada describe lo que cubre el documento; el propio documento es la autoridad. Incluirlo no implica estar de acuerdo con sus conclusiones.

Review and references

Reviewer

Automated FDA record verification

Published

2026-10-20

Updated

2026-10-29

Disclaimer

professional use

FDA 510(k) public index record K230349.

Device name: Lyra RSV+hMPV Assay. Applicant as listed: Quidel Corporation.

Decision date: 2023-03-10. Decision wording: Substantially Equivalent.

Product code: OEM. Regulation: 21 CFR 866.3980. Medical specialty: Microbiology.

This page reproduces regulator index metadata. The applicant field identifies the submitter and is not a manufacturer identity check. Consult the original FDA record for the decision and associated documents; this index does not verify current commercial availability or clinical performance.

Interested in these solutions?

Submit a sourcing request with the assays, volumes, and timeline of your own project.

Explorar más